Session identifies global differences in Middle Eastern dermatology

July 17, 2015

Hassan I. Galadari, MD

For the first time at an AAD meeting, the topic of dermatological issues in Middle Eastern countries will be covered in depth in the new session, “Coming to America: New Techniques, Products, and Tips from Experts in the New Old World” (F006). From 3 to 5 p.m. Thursday, Aug. 20, session director Hassan I. Galadari, MD, will lead a discussion on a variety of infectious, neoplastic, and cosmetic skin issues that are pertinent to the Middle Eastern population, and showcase the major distinctions in practice and treatment methodology.

From diseases not commonly seen in North America to unique correlations between beauty and ethnicity, Dr. Galadari will incorporate his experience as a dermatologist in his home city of Dubai — as well as his residency training in the U.S. — to bridge the gap between Western and Middle Eastern practice.

After coming to the U.S. for years to attend various meetings, the idea for the session came to Dr. Galadari when he recognized there was little to no discussion of the unique dermatological issues that affect his own patients.

“Every year, I would attend the meeting and realize that there was a dearth of focus on the area of my current practice,” he said. “It’s important for me to help showcase practices from abroad to my American and international colleagues.”

Today, the specialty still has many established guidelines that do not incorporate the needs of Middle Eastern patients. To help identify where modifications should be made, the session will focus on a set of topics that showcase disparities between Middle Eastern practices and the remainder of the world.

These topics, which will be covered by four additional speakers, include infectious diseases such as leprosy and leishmaniasis, non-melanoma/melanoma skin cancers, laser practices, soft tissue augmentation methods, Mohs application, and more. In addition, a number of unique cases from the Middle East that may never be seen in the rest of the world also will be studied.

The session offers attendees 2 CME credits. All registrants can attend. No ticket is required to attend.

According to a soon-to-be published @JAADjournals study, 67% of admitted #COVID19 patients presented with clinically relevant androgenetic ... #alopecia—suggesting the potential for anti-androgens to be used in the treatment of COVID-19. https://bit.ly/36ZiCIo #DermWorldWeekly

It’s #vitiligoawareness month. This condition presents in people of all skin colors and races, and nearly half get it before age 21. Share... these facts and more to help spread awareness about #vitiligo at https://bit.ly/2ADXz1X